ABSTRACT
The World Health Organization reported that cancer is the second leading cause of death globally and is re-
sponsible for 9.6 million deaths in 2018. Approximately 50% of all cancer patients receive radiation therapy
(RT). Many of them have metal implants, which induce image artifacts in the treatment planning CT images and
compromise or preclude treatment in an estimated 15% of all radiation therapy patients. Despite extensive CT
metal artifact reduction (MAR) research it remains one of the long-standing challenges in the CT field, without a
clinically satisfactory solution.
The overall goal of this project is to develop cutting-edge deep learning imaging methods and software solutions
for commercial CT scanners to eliminate CT metal artifacts in general and improve RT in particular. We propose
a three-pronged approach to systematically tackle this challenge in three specific aims: (1) adversarial learning
techniques for estimation of sinogram missing data and metal traces; (2) constrained disentanglement (CODE)
networks to remove CT image artifacts during image reconstruction, through post-processing, and in both data
and image domains; and (3) systematic evaluation of our proposed CT MAR techniques and clinical translation
into robust RT planning methods to maximize the RT treatment planning accuracy and thus improve patient
outcomes. Our synergistic track records in CT MAR research, especially with deep imaging methods over the
past three years, promises an unprecedented opportunity for a brand-new solution to CT MAR. For the first time
we will integrate contemporary AI innovations in data preprocessing, image reconstruction, post-processing,
observer studies and treatment planning synergistically in a unified data-driven framework, positioning this
project uniquely to eliminate metal artifacts and their complications in radiation therapy.
This project will be pursued through the long-term academic-industrial partnership among Dr. Ge Wang at Ren-
sselaer Polytechnic Institute (RPI), Dr. Bruno De Man at GE Research Center (GRC), and Dr. Harald Paganetti
at Massachusetts General Hospital (MGH). While our teams will collaborate closely through the whole project,
GRC has a history of CT research and translation, including direct raw data processing, and will focus on Aim 1.
RPI is a pioneering group in tomographic reconstruction, especially deep-learning-based CT imaging, and will
lead Aim 2. The MGH team is at the forefront of radiation therapy research and will be responsible for Aim 3.
Upon completion of this project, we will have redefined the state of the art of CT MAR, largely eliminating CT
metal artifacts and substantially improving radiation therapy planning and delivery accuracy. With the
above-proposed networks for CT MAR, metal artifacts will have been basically eliminated, targeting residual
errors <10 HU for photon and proton therapy planning, with the goal of reducing the clinical diametric error to
±3% and the proton range error due to metal artifacts to <2mm. Since our approach is software-based and
open-source, the path for technology transfer and clinical translation is clearly defined, as well tested before.
